CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands		Total	At-the-Market Offering	Subscription Agreement	Series B	Series C	Series D	Series E	Common Stock		Common Stock At-the-Market Offering	Common Stock Subscription Agreement	Additional Paid-In Capital	Additional Paid-In Capital At-the-Market Offering	Additional Paid-In Capital Subscription Agreement	Treasury Stock	Accumulated Other Comprehensive Loss	Accumulated Deficit
Preferred stock, beginning balance (in shares) at Dec. 31, 2019	[1]	502,582,534
Preferred stock, beginning balance at Dec. 31, 2019		$ 1,074,010
Increase (Decrease) in Temporary Equity [Roll Forward]
Extinguishment and reclassification of Series B convertible preferred stock					$ (4,000)
Repurchase of convertible preferred stock (in shares)	[1]					(11,507,389)
Repurchase of Series C convertible preferred stock						$ (24,885)
Issuance of convertible preferred shares (in shares)	[1]						164,992,213	301,092,346
Issuance of convertible preferred shares							$ 400,000	$ 898,932
Settlement of Series D contingent forward contract liability							$ 39,563	$ 110,456
Preferred stock, ending balance (in shares) at Dec. 31, 2020	[1]	957,159,704
Preferred stock, ending balance at Dec. 31, 2020		$ 2,494,076
Beginning balance (in shares) at Dec. 31, 2019	[1]								21,288,741
Beginning balance at Dec. 31, 2019		(621,080)							$ 2				$ 16,431			$ 0	$ 0	$ (637,513)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(719,380)																(719,380)
Extinguishment and reclassification of Series B convertible preferred stock		1,000											1,000
Net unrealized losses on investments, net of tax		0
Repurchase of Series C convertible preferred stock		12,784											12,784
Issuance of common stock upon exercise of stock options (in shares)	[1]								7,502,961
Issuance of common stock upon exercise of stock options		3,285							$ 1				3,284
Stock-based compensation		4,614											4,614
Ending balance (in shares) at Dec. 31, 2020	[1]								28,791,702
Ending balance at Dec. 31, 2020		$ (1,318,777)							$ 3				38,113			0	0	(1,356,893)
Increase (Decrease) in Temporary Equity [Roll Forward]
Repurchase of convertible preferred stock (in shares)	[1]				(3,525,365)
Issuance of Series D convertible preferred shares upon exercise of warrants (in shares)	[1]						1,546,799
Issuance of Series D convertible preferred stock upon exercise of warrants							$ 12,936
Issuance of convertible preferred shares (in shares)	[1]							200,728,229
Issuance of convertible preferred shares								$ 3,206,159
Stock-based compensation related to Series E convertible preferred stock								$ 123,614
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)	[1]	(1,155,909,367)
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization		$ (5,836,785)
Preferred stock, ending balance (in shares) at Dec. 31, 2021	[1]	0
Preferred stock, ending balance at Dec. 31, 2021		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(2,579,761)																(2,579,761)
Net unrealized losses on investments, net of tax		0
Issuance of Series E convertible preferred stock		(2,151,613)											(22,395)					(2,129,218)
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)	[1]								1,155,909,367
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization		5,836,785							$ 116				5,836,669
Issuance of common stock (in shares)	[1]								425,395,023
Issuance of common stock		3,590,956							$ 42				3,590,914
Issuance and sale of common stock for tax withholdings of employee RSUs		$ (22,063)											(22,063)
Treasury stock repurchase (in shares)		(857,825)							(857,825)	[1]
Treasury stock repurchase		$ (20,716)														(20,716)
Issuance of common stock upon vesting of employee RSUs (in shares)	[1]								601,176
Issuance of common stock upon exercise of common stock warrants (in shares)	[1]								26,640,121
Issuance of common stock upon exercise of common stock warrants		173,273							$ 3				173,270
Redemption of public warrants		(4)											(4)
Issuance of common stock upon exercise of stock options (in shares)	[1]								11,076,026
Issuance of common stock upon exercise of stock options		8,132							$ 1				8,131
Stock-based compensation		$ 393,143											393,143
Ending balance (in shares) at Dec. 31, 2021		1,647,555,590							1,647,555,590	[1]
Ending balance at Dec. 31, 2021		$ 3,909,355							$ 165				9,995,778			(20,716)	0	(6,065,872)
Preferred stock, beginning balance (in shares) at Jul. 22, 2021		437,182,072
Beginning balance (in shares) at Jul. 22, 2021		451,295,965
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)									1,155,909,367
Ending balance (in shares) at Jul. 23, 2021		1,618,621,534
Preferred stock, beginning balance (in shares) at Dec. 31, 2021	[1]	0
Preferred stock, ending balance (in shares) at Dec. 31, 2022	[1]	0
Preferred stock, ending balance at Dec. 31, 2022		$ 0
Beginning balance (in shares) at Dec. 31, 2021		1,647,555,590							1,647,555,590	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		$ (1,304,460)																(1,304,460)
Net unrealized losses on investments, net of tax		(11,572)															(11,572)
Issuance of common stock (in shares)	[1]										56,203,334	85,712,679
Issuance of common stock			$ 594,317	$ 915,000							$ 6	$ 9		$ 594,311	$ 914,991
Issuance and sale of common stock for tax withholdings of employee RSUs		$ (218,789)											(218,789)
Treasury stock repurchase (in shares)		0
Issuance of common stock upon vesting of employee RSUs (in shares)	[1]								15,217,096
Issuance of common stock upon vesting of employee RSUs		$ 0							$ 1				(1)
Issuance of common stock under employee stock purchase plan (in shares)	[1]								2,106,158
Issuance of common stock under employee stock purchase plan		$ 24,562											24,562
Issuance of common stock upon exercise of stock options (in shares)		22,519,879							22,519,879	[1]
Issuance of common stock upon exercise of stock options		$ 17,788							$ 2				17,786
Stock-based compensation		$ 423,500											423,500
Ending balance (in shares) at Dec. 31, 2022		1,829,314,736							1,829,314,736	[1]
Ending balance at Dec. 31, 2022		$ 4,349,701							$ 183				$ 11,752,138			$ (20,716)	$ (11,572)	$ (7,370,332)

[1] The number of shares of convertible preferred stock and common stock issued and outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio (as defined in Note 3 “Reverse Recapitalization”) to give effect to the reverse recapitalization treatment of the Merger. See Note 1 “Description of Business” and Note 3 “Reverse Capitalization” for more information.